|
|
|
|
| LEADER |
00000nam a2200000 a 4500 |
| 001 |
b2518400 |
| 003 |
CoU |
| 005 |
19950928092543.0 |
| 008 |
950928s1995 dcua f000 0 eng d |
| 020 |
|
|
|a 0160475058
|
| 035 |
|
|
|a (OCoLC)ocm33215258
|
| 035 |
|
|
|a (GPO)96059723
|
| 040 |
|
|
|a GPO
|c GPO
|d DLC
|d MvI
|
| 043 |
|
|
|a n-us---
|
| 049 |
|
|
|a COD9
|
| 074 |
|
|
|a 1019-A-01
|
| 074 |
|
|
|a 1019-B-01 (MF)
|
| 086 |
0 |
|
|a Y 4.C 73/8:104-23
|
| 086 |
0 |
|
|a Y 4.C 73/8:104-23
|
| 088 |
|
|
|a Serial no. 104-23 (United States. Congress. House. Committee on Commerce)
|
| 110 |
1 |
|
|a United States.
|b Congress.
|b House.
|b Committee on Commerce.
|b Subcommittee on Oversight and Investigations.
|0 http://id.loc.gov/authorities/names/no95033770.
|
| 245 |
1 |
0 |
|a Drugs and biologics :
|b hearings before the Subcommittee on Oversight and Investigations of the Committee on Commerce, House of Representatives, One Hundred Fourth Congress, first session, May 25, 1995-a consumer's perspective, June 19, 1995-FDA review process.
|
| 260 |
|
|
|a Washington :
|b U.S. G.P.O. :
|b For sale by the U.S. G.P.O., Supt. of Docs., Congressional Sales Office,
|c 1995.
|
| 300 |
|
|
|a iii, 175 pages :
|b illustrations ;
|c 24 cm.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent.
|
| 337 |
|
|
|a unmediated
|b n
|2 rdamedia.
|
| 338 |
|
|
|a volume
|b nc
|2 rdacarrier.
|
| 500 |
|
|
|a Distributed to some depository libraries in microfiche.
|
| 500 |
|
|
|a Shipping list number: 95-0306-P.
|
| 500 |
|
|
|a "Serial number 104-23."
|
| 590 |
|
|
|3 Documents in PASCAL:
|a FIPNet Preservation copy of record in partnership with the US Government Publishing Office. Electronic version is available, email govpubs@colorado.edu for help locating a digital copy.
|
| 610 |
1 |
0 |
|a United States.
|b Food and Drug Administration.
|0 http://id.loc.gov/authorities/names/n80126147
|1 http://isni.org/isni/0000000122433366.
|
| 650 |
|
0 |
|a Drugs
|x Bioavailability
|z United States.
|0 http://id.loc.gov/authorities/subjects/sh2010001375.
|
| 650 |
|
0 |
|a Drugs
|x Testing
|x Health aspects
|z United States.
|
| 650 |
|
0 |
|a Drugs
|x Testing
|x Economic aspects
|z United States.
|
| 856 |
4 |
2 |
|u https://www.hathitrust.org/
|z Search for the full-text version of this title in HathiTrust
|
| 907 |
|
|
|a .b25184003
|b 01-19-23
|c 02-05-96
|
| 998 |
|
|
|a gov
|a pas
|b 02-05-96
|c -
|d m
|e -
|f eng
|g dcu
|h 0
|i 1
|
| 907 |
|
|
|a .b25184003
|b 05-08-19
|c 02-05-96
|
| 944 |
|
|
|a MARS - RDA ENRICHED
|
| 907 |
|
|
|a .b25184003
|b 08-17-10
|c 02-05-96
|
| 907 |
|
|
|a .b25184003
|b 02-28-01
|c 02-05-96
|
| 999 |
f |
f |
|i f0937e4a-f4b7-51b8-b961-dee416d2b3a8
|s 689ad91c-3300-570e-9c60-f1d685435ba7
|
| 952 |
f |
f |
|p Can circulate
|a University of Colorado Boulder
|b Boulder Campus
|c Norlin
|d Norlin Library - Government Information - Microform
|e Y 4.C 73/8:104-23
|h Superintendent of Documents classification
|i document
|n 1
|
| 952 |
f |
f |
|p Reading room
|a University of Colorado Boulder
|b Boulder Campus
|c Offsite
|d PASCAL Offsite - Use in Reading Room Only
|e Y 4.C 73/8:104-23
|h Superintendent of Documents classification
|i gov pres steward
|m P201360706025
|n 1
|
